Access cutting-edge atrial fibrillation treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access atrial fibrillation specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related atrial fibrillation treatment provided free
The goal of the study is to learn how a weight loss medication called semaglutide, which is used to treat obesity, in addition to standard AF treatment might affect AF, atrial fibrillation severity, and whether it changes the risk of atrial fibrillation recurring after standard AF treatments.
Sponsor: University of Chicago
Check if you qualify for this atrial fibrillation clinical trial in Chicago, IL
If you're searching for atrial fibrillation treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced atrial fibrillation specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.